EV Based Platform for Monitoring Therapeutics Response During Pregnancy (ARISE)
Part of paid clinical trials in Columbus, Ohio.
- Sponsor
- Ohio State University
- Study ID
- NCT06249178
- Status
- Recruiting
Conditions
- Preeclampsia
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The goal of this prospective observational cohort study of pregnant people at-risk of preeclampsia receiving aspirin as part of clinical care or a planned randomized controlled trial of 81mg vs. 162mg of aspirin is to generate proteomic data to show a distinct maternal and fetal Extracellular Vesicle (EV) proteome profile with aspirin treatment, and develop and validate a multi-marker panel for the monitoring of placental function in people at-risk of Preeclampsia and in response to aspirin treatment. The primary research question is: 1\. Does the maternal and fetal Positive for Placental Alkaline Phosphatase (PLAP+) Extracellular Vesicle (EV) proteome profile in the 2nd and 3rd trimester of pregnancy differ between people who receive aspirin and develop (or not) preeclampsia? Participants will be asked to give blood samples up to four times during and at the end of their pregnancy.
Key Dates
- Start date
- Jul 2, 2024
- Status verified
- Dec 2025
- Primary completion
- Sep 1, 2028
- Completion
- Sep 1, 2028
Study Design
- Enrollment
- 1,000 participants (estimated)
Primary Outcome Measure
multi-marker panel [ Time Frame: From enrollment till delivery; up to 29 weeks ]
Central Contacts
- Maged Costantine, MD, MBA614-293-2222
- Kara Rood, MD614-293-8045
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine | Columbus | Ohio | 43210 | Kara Rood, MD (SUB_INVESTIGATOR) Mitch Phelps, PhD (SUB_INVESTIGATOR) Brian Searle, PhD (SUB_INVESTIGATOR) Damien Wilburn, PhD (SUB_INVESTIGATOR) |
Find similar trials in Columbus, OH
Related Studies
- Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in PregnancyRecruiting · The George Washington University Biostatistics Center · Birmingham, Alabama
- Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIALPHASE4 · Recruiting · Ohio State University · Birmingham, Alabama
- AtorvaStatin Postpartum and Reduction of Cardiovascular risKPHASE4 · Recruiting · Ohio State University · Columbus, Ohio
- Effects of High Altitude on AMPK ActivationRecruiting · University of Colorado, Denver · Aurora, Colorado